Related references
Note: Only part of the references are listed.The efficacy and safety of daunorubicin versus idarubicin combined with cytarabine for induction therapy in acute myeloid leukemia A meta-analysis of randomized clinical trials
Hanyu Wang et al.
MEDICINE (2020)
MRD in AML: The Role of New Techniques
Maria Teresa Voso et al.
FRONTIERS IN ONCOLOGY (2019)
Hematopoietic stem cell transplantation for acute myeloid leukemia
Akiyoshi Takami
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients
Jiayi Yu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML)
Utkarsh H. Acharya et al.
JOURNAL OF DRUG ASSESSMENT (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Acute myeloid leukemia: a comprehensive review and 2016 update
I. De Kouchkovsky et al.
BLOOD CANCER JOURNAL (2016)
Acute Myeloid Leukemia: A Concise Review
Jennifer N. Saultz et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
Carolyn S. Grove et al.
DISEASE MODELS & MECHANISMS (2014)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia
Krzysztof Mrozek et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Jay P. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting System
Christoph Roellig et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002
Jennifer F. Yamamoto et al.
CANCER CAUSES & CONTROL (2008)
Cancer prevalence in the UK: results from the EUROPREVAL study
D Forman et al.
ANNALS OF ONCOLOGY (2003)
Molecular genetics of acute myeloid leukaemia
A Dash et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2001)
Share Paper
